Nanexa AB (publ) (NANEXA)

Nasdaq First North Growth Market | Biotech | Drug development and delivery technology
Free
No email, no account, no signup.
Pulling latest news for Nanexa AB (publ)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
Nasdaq First North Growth Market
Type
Biotech
Sector
Drug development and delivery technology
Market Cap
$76M
We're already tracking Nanexa AB (publ) — here are the latest events we've registered

Recent News

  • On April 29, 2026, Nanexa reported Q1 results highlighting strong preclinical data for monthly and quarterly semaglutide formulations. During the spring, the company raised SEK 55.7 million through warrant exercises and resolved to set off its remaining SEK 20 million loan against new shares. Nanexa is also presenting its technology at the DDF Summit in Berlin in May 2026.
Want to know how this news affects Nanexa AB (publ)? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Nanexa AB (publ) will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
Nanexa AB (publ) (NANEXA)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.